Skip to content

Clinical trials

Obesity, Abdominal trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity, Abdominal Phase: Not applicable Clear all

188 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20042
20051
20061
20072
20081
20093
20102
20119
20128
20132
201411
20158
201610
20177
201813
201916
202011
202117
202215
202313
202413
202510
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed113
Unknown status30
Recruiting14
Active, not recruiting11
Not yet recruiting11
Withdrawn4
Enrolling by invitation3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cairo University11
Bogomolets National Medical University4
The University of Hong Kong4
Escola Superior de Tecnologia da Saúde do Porto3
Hospices Civils de Lyon3
Hubei Hospital of Traditional Chinese Medicine3
Laval University3
Maastricht University Medical Center3
Massachusetts General Hospital3
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity, Abdominal188
Obesity63
Metabolic Syndrome36
Insulin Resistance32
Hypertension17
Weight Loss17
Diabetes Mellitus, Type 215
Dyslipidemias11
Overweight10
Fatty Liver8

Trials

Showing 76 to 100 of 188. Each trial links to its page on Pharma Observatory.

88 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.